🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Has anyone dealt with surmount-2: tirzepatide for t2dm + obesity? Page 7

Has anyone dealt with surmount-2: tirzepatide for t2dm + obesity?

claudia_zurich Tue, Nov 5, 2024 at 8:00 PM 37 replies 1,853 viewsPage 7 of 8
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Nov 6, 2024 at 5:55 AM#31

To answer FranDenver's question specifically:

From a clinical standpoint, Has anyone dealt with is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

6 22rachel_ABQ, traveltech_sara, AttorneyGrant and 3 others
Reply Quote Save Share Report
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Nov 6, 2024 at 6:12 AM#32

LipidDoc_ATL — that is really helpful context on Has anyone dealt with. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

41 20fiona_VT, denise_HTX, raj_cambridge and 38 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Nov 6, 2024 at 6:29 AM#33

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Has anyone dealt with.

To answer claudia_zurich: I started tracking everything in a spreadsheet from day 1.

Quick update: I will post a proper update thread soon. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

29 6Dr.LipidDallas, alex_tucson, kevin_tulsa and 26 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Nov 6, 2024 at 6:46 AM#34

Congrats claudia_zurich!! You should be so proud of yourself. 🎉

Last edited: Nov 6, 2024 at 8:46 AM
11 21B12Beth, RickReta_CO, PharmHunterJen and 8 others
Reply Quote Save Share Report
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Nov 6, 2024 at 7:03 AM#35

Can confirm — identical experience.

Last edited: Nov 6, 2024 at 8:03 AM
26 3PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 23 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register